Beskrivning
Dendritic cells (DCs) are the most potent antigen-presenting cells in the human body, serving as a bridge between innate and adaptive immunity. However, their extremely low abundance in vivo makes direct isolation difficult, which significantly limits DC research and applications. Nevertheless, DCs can be generated through the differentiation and induction of DC precursor cells from various tissues, such as bone marrow precursors, peripheral blood monocytes, and umbilical cord blood monocytes. For human studies, the most commonly used method is inducing DCs from human peripheral blood mononuclear cells (PBMCs), as peripheral blood is the most accessible source and yields the highest number of monocytes.
This cytokine set includes recombinant human GM-CSF, IL-4, IL-6, TNF-α, and IL-1β. IL-4 inhibits the differentiation of monocytes into CD14+ macrophages, thereby inducing their differentiation into immature DCs. Without IL-4 in the culture system, monocytes will differentiate into macrophages. GM-CSF induces the differentiation of monocytes or DC precursors into DCs, while promoting DC proliferation and survival. Furthermore, GM-CSF upregulates surface antigens on DCs, enhancing their capacity for antigen capture and processing. The combined action of GM-CSF and IL-4 drives the directed differentiation of monocytes into immature DCs. The combination of TNF-α, IL-6, and IL-1β induces the complete maturation of DCs.
Specifications
|
Cat.No. |
92670ES70 / 92670ES80 |
|
Size |
200 mL / 1000 mL |
Components
|
Component Number |
Component Name |
92670ES70 |
92670ES80 |
|
92670-A |
Recombinant Human GM-CSF |
20 μg |
100 μg |
|
92670-B |
Recombinant Human IL-4 |
10 μg(2×5 μg) |
50 μg |
|
92670-C |
Recombinant Human IL-6 |
10 μg |
50 μg |
|
92670-D |
Recombinant Human TNF-a |
10 μg |
10 μg |
|
92670-E |
Recombinant Human IL-1β |
10 μg |
10 μg |
Product information
|
Original Cat. No. |
Product Name |
Source |
Appearance |
Reference Concentration |
|
91102ES |
Recombinant Human GM-CSF |
E.coli |
Lyophilized Powder |
100 ng/mL |
|
90105ES |
Recombinant Human IL-4 |
E.coli |
Lyophilized Powder |
50 ng/mL |
|
90107ES |
Recombinant Human IL-6 |
E.coli |
Lyophilized Powder |
50 ng/mL |
|
90635ES |
Recombinant Human TNF-a |
E.coli |
Lyophilized Powder |
10 ng/mL |
|
90101ES |
Recombinant Human IL-13 |
E.coli |
Lyophilized Powder |
10 ng/mL |
Reconstitution Method
|
Component Name |
Resuspension method |
|
Human GM-CSF Protein Human IL-4 Protein Human IL-6 Preotein Human TNF-a Preotein Human IL-1β Preotein |
Before opening the vial, centrifuge it first to bring the contents to the bottom. Res uspend with sterile water and reconstitute to a concentration of 0.1–1.0 mg/mL; f urther dilution can be performed according to subsequent experiments. For long term storage, it is recommended to add a carrier protein (0.1% BSA) to the dilutio n buffer. Aliquot into single-use amounts, freeze at -80℃, and avoid repeated fre eze-thaw cycles. |
Storage Conditions
Store at -25 ~ -15℃. Valid for 1 year from the date of receipt. After reconstitution, store at 2 ~ 8℃ under aseptic conditions, valid for 7 days. Alternatively, after reconstitution, store at -85 ~ -65℃ under aseptic conditions, valid for 3 months.
Notes
1. For your safety and health, please wear a lab coat and disposable gloves during handling. This product is for research use only.
Documents:
Safety Data Sheet
Manuals:
Betalning och säkerhet
Din betalningsinformation behandlas säkert. Vi lagrar inte kreditkortsuppgifter och har inte heller tillgång till din kreditkortsinformation.
Du kanske också gillar
Förfrågan
Vanliga frågor
Produkten är endast avsedd för forskningsändamål och är inte avsedd för terapeutisk eller diagnostisk användning hos människor eller djur. Produkter och innehåll skyddas av patent, varumärken och upphovsrätt som ägs av Yeasen Biotechnology. Varumärkessymboler anger ursprungsland, inte nödvändigtvis registrering i alla regioner.
Vissa applikationer kan kräva ytterligare immateriella rättigheter från tredje part.
Yeasen är dedikerad till etisk vetenskap, och anser att vår forskning bör behandla kritiska frågor samtidigt som den säkerställer säkerhet och etiska standarder.